Armata Pharmaceuticals Inc (ARMP)

Currency in USD
2.390
-0.095(-3.82%)
Closed·
After Hours
2.3900.000(0.00%)
·
ARMP Scorecard
Full Analysis
Operates with a significant debt burden
ARMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3502.560
52 wk Range
0.8983.000
Key Statistics
Prev. Close
2.485
Open
2.35
Day's Range
2.35-2.56
52 wk Range
0.898-3
Volume
5.24K
Average Volume (3m)
248.42K
1-Year Change
-17.87%
Book Value / Share
-1.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.000
Upside
+276.57%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Armata Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Armata Pharmaceuticals Inc Company Profile

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.

Compare ARMP to Peers and Sector

Metrics to compare
ARMP
Peers
Sector
Relationship
P/E Ratio
−203.1x−4.7x−0.5x
PEG Ratio
−4.000.000.00
Price/Book
−1.6x6.1x2.6x
Price / LTM Sales
18.4x9.3x3.2x
Upside (Analyst Target)
276.6%112.0%41.4%
Fair Value Upside
Unlock15.7%6.0%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.000
(+276.57% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.20 / -0.16
Revenue / Forecast
491.00K / --
EPS Revisions
Last 90 days

ARMP Income Statement

People Also Watch

569.74
NOC
+0.22%
3.280
ADCT
+1.55%
735.01
AXON
+3.63%
115.62
CRWV
-3.65%
1.97
CTOR
+1.03%

FAQ

What Stock Exchange Does Armata Pharma Trade On?

Armata Pharma is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Armata Pharma?

The stock symbol for Armata Pharma is "ARMP."

What Is the Armata Pharma Market Cap?

As of today, Armata Pharma market cap is 86.50M.

What Is Armata Pharma's Earnings Per Share (TTM)?

The Armata Pharma EPS (TTM) is -0.01.

When Is the Next Armata Pharma Earnings Date?

Armata Pharma will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is ARMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Armata Pharma Stock Split?

Armata Pharma has split 4 times.

How Many Employees Does Armata Pharma Have?

Armata Pharma has 60 employees.

What is the current trading status of Armata Pharma (ARMP)?

As of 27 Jul 2025, Armata Pharma (ARMP) is trading at a price of 2.39, with a previous close of 2.49. The stock has fluctuated within a day range of 2.35 to 2.56, while its 52-week range spans from 0.90 to 3.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.